Wasserman D - Search Results

1

A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy Trials.

Hendriks S, Grady C, Wasserman D, Wendler D, Bianchi DW, Berkman BE. Hendriks S, et al. Among authors: wasserman d. Am J Bioeth. 2022 Mar;22(3):45-61. doi: 10.1080/15265161.2020.1867932. Epub 2021 Jan 16. Am J Bioeth. 2022. PMID: 33455521 Free PMC article.

2

A new ethical framework to determine acceptable risks in fetal therapy trials.

Hendriks S, Grady C, Wasserman D, Wendler D, Bianchi DW, Berkman B. Hendriks S, et al. Among authors: wasserman d. Prenat Diagn. 2022 Jul;42(8):962-969. doi: 10.1002/pd.6163. Epub 2022 May 6. Prenat Diagn. 2022. PMID: 35506484 Free PMC article. Review.

3

Views of American OB/GYNs on the ethics of prenatal whole-genome sequencing.

Bayefsky MJ, White A, Wakim P, Hull SC, Wasserman D, Chen S, Berkman BE. Bayefsky MJ, et al. Among authors: wasserman d. Prenat Diagn. 2016 Dec;36(13):1250-1256. doi: 10.1002/pd.4968. Epub 2016 Dec 6. Prenat Diagn. 2016. PMID: 27862072

4

Autonomy-based criticisms of the patient preference predictor.

Jardas EJ, Wasserman D, Wendler D. Jardas EJ, et al. Among authors: wasserman d. J Med Ethics. 2022 May;48(5):304-310. doi: 10.1136/medethics-2021-107629. Epub 2021 Dec 17. J Med Ethics. 2022. PMID: 34921123 Review.

5

A Framework for Unrestricted Prenatal Whole-Genome Sequencing: Respecting and Enhancing the Autonomy of Prospective Parents.

Chen SC, Wasserman DT. Chen SC, et al. Am J Bioeth. 2017 Jan;17(1):3-18. doi: 10.1080/15265161.2016.1251632. Am J Bioeth. 2017. PMID: 27996923

6

Disability, diversity, and preference for the status quo: bias or justifiable preference?

Wasserman D. Wasserman D. Am J Bioeth. 2015;15(6):11-2. doi: 10.1080/15265161.2015.1028676. Am J Bioeth. 2015. PMID: 26030485 No abstract available.

7

Considering Consent to Research for Patients in Chronic Pain and With Mental Illnesses.

Huang CJ, Wasserman D. Huang CJ, et al. Among authors: wasserman d. Am J Bioeth. 2017 Dec;17(12):51-52. doi: 10.1080/15265161.2017.1388877. Am J Bioeth. 2017. PMID: 29148950 Free PMC article. No abstract available.

8

What Are the Wider Implications of Sparrow's Benefit Argument?

Wasserman D. Wasserman D. Am J Bioeth. 2022 Sep;22(9):28-30. doi: 10.1080/15265161.2022.2105433. Am J Bioeth. 2022. PMID: 36040895 No abstract available.

9

Restricting Access, Stigmatizing Disability?

Berens N, Wasserman D. Berens N, et al. Among authors: wasserman d. Am J Bioeth. 2022 Feb;22(2):25-27. doi: 10.1080/15265161.2021.2013989. Am J Bioeth. 2022. PMID: 35089832 No abstract available.

10

Response to Open Peer Commentaries on "A Framework for Unrestricted Prenatal Whole-Genome Sequencing: Respecting and Enhancing the Autonomy of Prospective Parents".

Chen SC, Wasserman DT. Chen SC, et al. Am J Bioeth. 2017 Jan;17(1):W1-W3. doi: 10.1080/15265161.2016.1260784. Am J Bioeth. 2017. PMID: 27996911 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

800 results

Search Page